Sponsor pipeline

Changchun GeneScience Pharmaceutical Co., Ltd. clinical trial pipeline

Get alerts when Changchun GeneScience Pharmaceutical Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

5 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 3 with minor changes only.

Show 3 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-25 NCT07841678 A Phase III Clinical Study of Jinpei Growth Hormone Injection in the Treatment of Short… Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
24
Phase 1/2
3
Phase 2
7
Phase 3
9
Phase 4
2
Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 50

NCT IDTitleConditionStatusUpdated
Phase 4
NCT07691125 Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome Short Bowel Syndrome (SBS) in Adults Recruiting 2026-07-08
NCT07243379 A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in… Clinical Characteristics and Treatment Outcomes of Malignant Tumor Cachexia Recruiting 2025-11-21
Phase 3
NCT07124221 A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate… Hyperprolactinemia Recruiting 2025-10-02
NCT07150663 Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced… Non-small Cell Lung Cancer Recruiting 2025-09-08
NCT07841678 A Phase III Clinical Study of Jinpei Growth Hormone Injection in the Treatment of Short… Small for Gestational Age Not Yet Recruiting 2026-09-25
NCT07356037 Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular… Cachexia Not Yet Recruiting 2026-01-21
NCT06449027 Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for… Breast Cancer Subjects Active, Not Recruiting 2025-10-01
NCT06961188 Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight… Metastatic (Stage IV) Non-squamous Non-small Cell Lung Cancer (Nsq-NSCLC) With Driver Gene Negativity Not Yet Recruiting 2025-05-07
NCT06961201 Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard… Extensive-stage Small Cell Lung Cancer (ES-SCLC) Not Yet Recruiting 2025-05-07
NCT06772428 Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck… Head and Neck Squamous Cell Carcinoma; Underwent Surgery Within 6 Weeks and Postoperative Assessment Indicated High-risk Factors Not Yet Recruiting 2025-01-13
NCT06561594 To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection… Idiopathic Hypogonadotropic Hypogonadism Not Yet Recruiting 2024-08-20
Phase 2
NCT07547995 A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. Uveitis Recruiting 2026-07-24
NCT07423533 Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in… Rheumatoid Arthritis Recruiting 2026-05-22
NCT07260500 A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age… Short Stature Children Born Small for Gestational Age (SGA) Recruiting 2026-02-17
NCT06963177 A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients… Endometriosis-related Pain Recruiting 2025-08-12
NCT06189495 A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the… Systemic Sclerosis Associated Interstitial Lung Disease Recruiting 2025-01-17
NCT03255694 A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of… Dwarfism Active, Not Recruiting 2025-08-15
NCT02375620 Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short… Short Stature Children Born Small for Gestational Age (SGA) Active, Not Recruiting 2025-05-25
Phase 1/2
NCT07264595 A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone… Pediatric Growth Hormone Deficiency Recruiting 2026-09-16
NCT07450001 A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) Pediatric Growth Hormone Deficiency Not Yet Recruiting 2026-03-04
NCT07450053 A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS) Idiopathic Short Stature Not Yet Recruiting 2026-03-04
Phase 1
NCT07663838 A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the… Randomized Recruiting 2026-10-15
NCT07366866 A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults. Autoimmune Disease Recruiting 2026-10-14
NCT07407504 GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated… Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated Recruiting 2026-09-25
NCT07685210 GenSci144 Tablets Phase I Clinical Trial Phenylketonuria Recruiting 2026-07-06

Disease areas by active trials

Get alerts when Changchun GeneScience Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free